We are excited to announce that Cognivue’s peer-reviewed article, “Validity, reliability and psychometric properties of a computerized cognitive assessment” was published in the World Journal of Psychiatry (WJP). Cognivue is an important and innovative psychometric tool for cognitive evaluation. This article describes data that are fundamental indicators of its sophistication in evaluating cognitive impairment and cost-effective applicability in clinical practice.
Incorporating Cognivue Thrive can expand the diagnostic assessment of the patient’s overall health picture, allowing more comprehensive vision care.Dr. Michael Pier, OD.
Validity, Reliability, and Psychometric Properties of a Computerized, Cognitive Assessment Test (Cognivue)
Comparison of the Cognivue Quantitative Assessment Tool and SLUMS to Classify the Risk of Cognitive Impairment
Validation, Reliability, and Psychometric Properties of Cognivue, A Quantitative Assessment of Cognitive Impairment
Cognivue, Inc. Initiates Nationwide Clinical Study to Assess Post-COVID-19 Syndrome (Long Haul Syndrome)
ROCHESTER, N.Y., July 8, 2021—Neuroscience company Cognivue, Inc. today announced the initiation of COG-COVID19, an open-label, prospective, two-armed comparison clinical study to assess the impact of COVID-19 on cognitive function. Researchers from…
Sign-up to schedule a Cognivue demo!Click Here